Anastasaki C - Search Results

1

Stem cell modeling of nervous system tumors.

Furnari FB, Anastasaki C, Bian S, Fine HA, Koga T, Le LQ, Rodriguez FJ, Gutmann DH. Furnari FB, et al. Among authors: anastasaki c. Dis Model Mech. 2024 Feb 1;17(2):dmm050533. doi: 10.1242/dmm.050533. Epub 2024 Feb 14. Dis Model Mech. 2024. PMID: 38353122 Free PMC article. Review.

2

Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation.

Anastasaki C, Gutmann DH. Anastasaki C, et al. Hum Mol Genet. 2014 Dec 20;23(25):6712-21. doi: 10.1093/hmg/ddu389. Epub 2014 Jul 28. Hum Mol Genet. 2014. PMID: 25070947 Free PMC article.

3

Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.

Anastasaki C, Woo AS, Messiaen LM, Gutmann DH. Anastasaki C, et al. Hum Mol Genet. 2015 Jun 15;24(12):3518-28. doi: 10.1093/hmg/ddv103. Epub 2015 Mar 18. Hum Mol Genet. 2015. PMID: 25788518 Free PMC article.

4

NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Toonen JA, Anastasaki C, Smithson LJ, Gianino SM, Li K, Kesterson RA, Gutmann DH. Toonen JA, et al. Among authors: anastasaki c. Hum Mol Genet. 2016 May 1;25(9):1703-13. doi: 10.1093/hmg/ddw039. Epub 2016 Feb 16. Hum Mol Genet. 2016. PMID: 26908603 Free PMC article.

5

Contextual signaling in cancer.

Smithson LJ, Anastasaki C, Chen R, Toonen JA, Williams SB, Gutmann DH. Smithson LJ, et al. Among authors: anastasaki c. Semin Cell Dev Biol. 2016 Oct;58:118-26. doi: 10.1016/j.semcdb.2016.06.002. Epub 2016 Jun 3. Semin Cell Dev Biol. 2016. PMID: 27269372 Free PMC article. Review.

6

Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.

Li K, Turner AN, Chen M, Brosius SN, Schoeb TR, Messiaen LM, Bedwell DM, Zinn KR, Anastasaki C, Gutmann DH, Korf BR, Kesterson RA. Li K, et al. Among authors: anastasaki c. Dis Model Mech. 2016 Jul 1;9(7):759-67. doi: 10.1242/dmm.025783. Epub 2016 Jun 2. Dis Model Mech. 2016. PMID: 27482814 Free PMC article.

7

Human stem cell modeling in neurofibromatosis type 1 (NF1).

Wegscheid ML, Anastasaki C, Gutmann DH. Wegscheid ML, et al. Among authors: anastasaki c. Exp Neurol. 2018 Jan;299(Pt B):270-280. doi: 10.1016/j.expneurol.2017.04.001. Epub 2017 Apr 6. Exp Neurol. 2018. PMID: 28392281 Free PMC article. Review.

8

KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth.

Anastasaki C, Dahiya S, Gutmann DH. Anastasaki C, et al. Oncotarget. 2017 Jul 18;8(29):47574-47585. doi: 10.18632/oncotarget.17736. Oncotarget. 2017. PMID: 28548933 Free PMC article.

9

Updated nomenclature for human and mouse neurofibromatosis type 1 genes.

Anastasaki C, Le LQ, Kesterson RA, Gutmann DH. Anastasaki C, et al. Neurol Genet. 2017 Jul 26;3(4):e169. doi: 10.1212/NXG.0000000000000169. eCollection 2017 Aug. Neurol Genet. 2017. PMID: 28804759 Free PMC article. No abstract available.

10

Characterization of early communicative behavior in mouse models of neurofibromatosis type 1.

Maloney SE, Chandler KC, Anastasaki C, Rieger MA, Gutmann DH, Dougherty JD. Maloney SE, et al. Among authors: anastasaki c. Autism Res. 2018 Jan;11(1):44-58. doi: 10.1002/aur.1853. Epub 2017 Aug 26. Autism Res. 2018. PMID: 28842941 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters